Omega Therapeutics, Inc. Common Stock
OMGA
OMGA was delisted on the 24th of February, 2025.
45 hedge funds and large institutions have $480M invested in Omega Therapeutics, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 7 reducing their positions, and 6 closing their positions.
143% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 7
33% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 6
5% more funds holding
Funds holding: 43 → 45 (+2)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
38% less capital invested
Capital invested by funds: $773M → $480M (-$293M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
+$30.8M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.34M |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$1.42M |
| 4 |
BlackRock
New York
|
+$1.4M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.05M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$4.12M |
| 2 |
OCA
Octagon Capital Advisors
New York
|
-$3.69M |
| 3 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$3.33M |
| 4 |
MS
Maven Securities
St Helier,
Jersey
|
-$2.79M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.74M |
OMGA Hedge Fund Activity: Q4 2021 in Review
45 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Omega Therapeutics, Inc. Common Stock (OMGA) for Q4 2021, worth a combined $480M — down 38% from $773M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new OMGA positions and 6 closed out — a net gain of 2 holders — while 17 added to existing stakes and 7 trimmed.
The largest buyer was State of Wisconsin Investment Board, adding an estimated $30.8M. The largest seller was Millennium Management, exiting entirely with an estimated $4.12M sold.
- 45 institutional investors held Omega Therapeutics, Inc. Common Stock (OMGA) as of Q4 2021, up from 43 in Q3 2021.
- Funds reported $480M of Omega Therapeutics, Inc. Common Stock stock for Q4 2021, down 38% quarter-over-quarter.
- 8 funds opened new Omega Therapeutics, Inc. Common Stock positions in Q4 2021 and 6 closed out, a net change of +2 holders.
- The largest Omega Therapeutics, Inc. Common Stock buyer in Q4 2021 was State of Wisconsin Investment Board, an estimated $30.8M added.
- The largest Omega Therapeutics, Inc. Common Stock seller in Q4 2021 was Millennium Management, an estimated $4.12M sold.
Based on aggregated 13F filings for Q4 2021.